tiprankstipranks
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
PremiumPress ReleasesVivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
1M ago
VVOS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VVOS Earnings this Week: How Will it Perform?
1M ago
LivaNova jumps nearly 12% after saying  trial likely to meet primary endpoint
PremiumThe Fly
LivaNova jumps nearly 12% after saying trial likely to meet primary endpoint
1M ago
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
PremiumPress ReleasesVivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
3M ago
Vivos Therapeutics seeing positive preliminary metrics following FDA clearance
PremiumThe Fly
Vivos Therapeutics seeing positive preliminary metrics following FDA clearance
4M ago
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
PremiumPress Releases
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
4M ago
Vivos Therapeutics receives FDA clearance for oral device treatment for OSA
PremiumThe FlyVivos Therapeutics receives FDA clearance for oral device treatment for OSA
5M ago
Vivos Therapeutics files to sell 2.94M shares of common stock for holders
PremiumThe Fly
Vivos Therapeutics files to sell 2.94M shares of common stock for holders
5M ago
Vivos Therapeutics, Inc. (VVOS) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Vivos Therapeutics, Inc. (VVOS) Q3 Earnings Cheat Sheet
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100